Author

Yannick De Vlaeminck

Observed names: De Vlaeminck, Y., De Vlaeminck, Yannick, Y De Vlaeminck, Y. De Vlaeminck

Institution: Vrije Universiteit Brussel

Observed institutions: Vrije Universiteit Brussel, Ghent University Hospital, Universitair Ziekenhuis Brussel

ORCID: 0000-0002-1882-4740

Observed ORCID: 0000-0002-1882-4740

OpenAlex ID: A5073798404

Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression

2018 · Robin Maximilian Awad, Yannick De Vlaeminck, et al. · Frontiers in Immunology · 153

PDF

Theranostics in immuno-oncology using nanobody derivatives

2019 · Quentin Lecocq, Yannick De Vlaeminck, et al. · Theranostics · 145

TUBA1A mutations

2011 · A.C. Jansen, A. Oostra, et al. · Neurology · 71

Cancer-Associated Myeloid Regulatory Cells

2016 · Yannick De Vlaeminck, Anna González-Rascón, et al. · Frontiers in Immunology · 69

PDF

Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use

2019 · Quentin Lecocq, Katty Zeven, et al. · Biomolecules · 56

PDF

Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade

2021 · Quentin Lecocq, Robin Maximilian Awad, et al. · Journal of Nuclear Medicine · 44

PDF

Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development

2020 · Yannick De Vlaeminck, Stefano Bonelli, et al. · Cancers · 36

Targeted α-Therapy Using225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

2023 · Thomas Ertveldt, Ahmet Krasniqi, et al. · Journal of Nuclear Medicine · 32

PDF

Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells

2019 · Inès Dufait, Julian Pardo, et al. · Cancers · 26

PDF

Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages

2019 · Yannick De Vlaeminck, Quentin Lecocq, et al. · Journal of Controlled Release · 23

PDF

Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177–Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model

2022 · Thomas Ertveldt, Lien De Beck, et al. · Molecular Cancer Therapeutics · 22

PDF

Emerging applications of nanobodies in cancer therapy

2022 · Robin Maximilian Awad, Fien Meeus, et al. · International review of cytology · 21

PDF

Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity

2024 · Fien Meeus, Cyprine Neba Funeh, et al. · Journal for ImmunoTherapy of Cancer · 19

PDF

TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy

2022 · Kirsten De Ridder, Hanne Locy, et al. · Frontiers in Immunology · 19

PDF

Antigen-presenting cell-targeted lentiviral vectors do not support the development of productive T-cell effector responses: implications for in vivo targeted vaccine delivery

2017 · C Goyvaerts, Y De Vlaeminck, et al. · Gene Therapy · 18

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

2021 · Robin Maximilian Awad, Quentin Lecocq, et al. · Molecular Therapy — Methods & Clinical Development · 15

Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine

2023 · Thomas Ertveldt, Sofie Meulewaeter, et al. · Theranostics · 14

PDF

In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells

2023 · Robin Maximilian Awad, Yannick De Vlaeminck, et al. · Scientific Reports · 12

PDF

Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma

2022 · Lien De Beck, Robin Maximilian Awad, et al. · Frontiers in Immunology · 12

Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties

2024 · Heleen Hanssens, Fien Meeus, et al. · International Journal of Molecular Sciences · 11

MSH2 knock-down shows CTG repeat stability and concomitant upstream demethylation at the DMPK locus in myotonic dystrophy type 1 human embryonic stem cells

2020 · Silvie Franck, Lise Barbé, et al. · Human Molecular Genetics · 11

PDF

Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer

2021 · Q. Lecocq, P. Debie, et al. · EJNMMI Research · 9

PDF

B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape

2025 · Arne Van der Vreken, Fien Meeus, et al. · Journal of Hematology & Oncology · 8

PDF

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

2024 · Heleen Hanssens, Fien Meeus, et al. · Frontiers in Immunology · 7

PDF

Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumors

2025 · Fien Meeus, Arne Van der Vreken, et al. · Molecular Therapy Oncology · 3

Works count: 48

Citation count: 857

H-index: 15

I10-index: 21